Healthcare and Pharmaceuticals
Global Anticoagulants Market was valued at USD XX billion in the year 2017. Global Anticoagulants market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.
In the Global Anticoagulants Market, by region Asia Pacific region holds the highest market share in 2017 and is also market is considered as the fastest growing market in the forecasted period owing to their market demands. At a country level, China and India in Asia-Pacific are projected to grow strongly in the coming years due to continued economic development with developing healthcare infrastructure and improving healthcare awareness.
Increase in the prevalence of atrial fibrillation, venous thromboembolism, and stroke
Changing government regulations and norms.
High price of NOACs
Growth opportunities in emerging markets
Poor demand in underdeveloped countries
The global anticoagulants market is segmented based on drug class, route of administration, application, and region. On the basis of drug class, the anticoagulants market is classified as NOACs, heparin and LMWH, vitamin K antagonist, and others. By route of administration, the market is segmented as an oral anticoagulant and injectable anticoagulant. The various application markets are atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others.
Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, GlaxoSmithKline plc., Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Pfizer, Inc., Portola Pharmaceuticals, Inc., and Sanofi S.A. are some of the key players in the Global Anticoagulants market.
Key Benefits for Stakeholders
Anticoagulants Manufacturers, Distributors, and Retailers
Raw material suppliers
Research and Consulting Organization
Healthcare institution and pharmaceutical companies
Investment research firms
By Drug Class
Savaysa & lixiana
Heparin & LMWH
Vitamin K Antagonist
By Route of Administration
Atrial fibrillation & heart attack
Deep vein thrombosis (DVT)
Pulmonary embolism (PE)
Key Market Players
Bristol-Myers Squibb Company
Boehringer Ingelheim Pharma GmbH & Co. KG
Daiichi Sankyo Co., Ltd.
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Portola Pharmaceuticals, Inc.
(A brief overview of 10 companies is also provided in a report.)
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
220.127.116.11. Key Data from Secondary Research
2.1.2. Primary Research
18.104.22.168. Key Data from Primary Research
22.214.171.124. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottom-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
3. Executive Summary
4. Market Overview
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Anticoagulants Market, By Drug Class
6.1.4 Savaysa & lixiana
6.2 Heparin & LMWH
6.3 Vitamin K Antagonist
7. Anticoagulants Market, By Route of Administration
7.1 Oral anticoagulant
7.2 Injectable anticoagulant
8. Anticoagulants Market, By Application
8.1 Atrial fibrillation & heart attack
8.3 Deep vein thrombosis (DVT)
8.4 Pulmonary embolism (PE)
9. Geographical Analysis
9.2. North America
9.4. Asia Pacific
9.4.1. South Korea
9.5.1. Latin America
9.5.2. Middle East and Africa
10. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
10.1 Aspen Holdings
10.2 Bristol-Myers Squibb Company
10.3 Bayer AG
10.4 GlaxoSmithKline Plc.
10.5 Boehringer Ingelheim Pharma GmbH & Co. KG
10.6 Daiichi Sankyo Co., Ltd.
10.7 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
10.8 Pfizer Inc.
10.9. Portola Pharmaceuticals, Inc.
(A brief overview of 10 companies is also provided in a report)
11. Competitive Analysis
11.2. Market Positioning of Key Players
11.3 Competitive Strategies Adopted by Leading Players
11.3.1. Investments & Expansions
11.3.2. New Product Launches
11.3.3. Mergers & Acquisitions
11.3.4. Agreements, Joint Ventures, and Partnerships
12.2. Available Customizations
12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
* The list of tables and figures will be provided in the sample report.
No Content Available.